Model Number SOFTECI+22.5 |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
|
Patient Problems
Toxic Anterior Segment Syndrome (TASS) (4469); Unspecified Eye / Vision Problem (4471)
|
Event Date 01/21/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
A full audit of all batch documentation relating to the production of the device was performed.The audit concluded that all procedures in manufacturing and packaging of the device had been conducted correctly.Batch reconciliation was 100.0%.Based on the assessment of our batch documentation, lenstec can confirm that all procedures in the manufacturing and packaging of the lens were conducted correctly.The device remains implanted and the patient symptoms resolved.Lenstec can also confirm that there have never been any confirmed lens-related cases of clouding, discoloration or opacification of our hema lenses.There is no evidence to suggest that any aspect of this device was responsible for the reported inflammation.A supplemental report will be submitted once a medical monitor assessment is complete.
|
|
Event Description
|
Lenstec received an email stating " the surface of softec i crystal appears similar to ground glass, with a layer of white material attached.After implantation of the crystal, the patient appears inflammation, and the inflammation is severe.Two or three days after the operation, the white material attached to the crystal surface disappeared, and the inflammation remained.The phemomenon of crystal has appeared many times".
|
|
Event Description
|
Lenstec received an email stating " the surface of softec i crystal appears similar to ground glass, with a layer of white material attached.After implantation of the crystal, the patient appears inflammation, and the inflammation is severe.Two or three days after the operation, the white material attached to the crystal surface disappeared, and the inflammation remained.The phenomenon of crystal has appeared many times".
|
|
Manufacturer Narrative
|
A full audit of all batch documentation relating to the production of the device was performed.The audit concluded that all procedures in manufacturing and packaging of the device had been conducted correctly.Batch reconciliation was 100.0%.Based on the assessment of our batch documentation, lenstec can confirm that all procedures in the manufacturing and packaging of the lens were conducted correctly.The device remains implanted and the patient symptoms resolved.Lenstec can also confirm that there have never been any confirmed lens-related cases of clouding, discoloration or opacification of our hema lenses.There is no evidence to suggest that any aspect of this device was responsible for the reported inflammation.
|
|
Search Alerts/Recalls
|